Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if adding inhaled Nitric Oxide to other malaria
treatments can improve the outcome of cerebral malaria in children aged 2months to 12 years.
Phase:
Phase 2
Details
Lead Sponsor:
Epicentre
Collaborators:
Harvard Medical School Harvard Medical School (HMS and HSDM) Massachusetts General Hospital Mbarara University of Science and Technology Medecins Sans Frontieres, Netherlands